-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Chromocell Therapeutics Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2023 to Q2 2024.
- Chromocell Therapeutics Corp Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$7.53K, a 95.7% increase year-over-year.
- Chromocell Therapeutics Corp annual Nonoperating Income (Expense) for 2023 was -$519K, a 269% decline from 2022.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)